The global BPH treatment market is expected to grow from USD 33,031.10 million in 2024 to USD 47,045.80 million by 2034, at a ...

Manipal Hospitals Sarjapur Road hosted a session on HoLEP for Benign Prostatic Hyperplasia. This innovative technique, led by ...

Winter leads to an increased risk of problems related to the prostate gland in seniors. Cold weather causes urinary and ...

Benign prostatic hyperplasia, also known as benign prostatic obstruction or benign prostatic ... Drugs may also be offered, such as alpha-adrenoceptor blockers and 5 alpha-reductase inhibitors. If ...

Several conditions can lead to urinary flow problems. In men, prostate changes often affect urination patterns, particularly ...

Despite a big increase in “watchful waiting” in the past 15 years, there’s a new study from the U.S. Department of Veterans Affairs health system shows that overtreatment of prostate cancer persists.

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Urology of Virginia is proud to announce the opening of our state-of-the-art Interventional Radiology Department, a milestone ...

PRNewswire Bangalore Karnataka [India] January 15 Manipal Hospitals Sarjapur Road recently hosted an awareness session on ...

Aquablation combines high-definition ultrasound imaging and a precise high-pressure water jet controlled by AI-powered ...

--(BUSINESS WIRE)--MarinHealth Medical Center (MHMC) announced today that its surgeons have performed the first Aquablation procedures to treat benign prostatic hyperplasia (BPH). MarinHealth is ...

We are excited to reach this important milestone in the Expander-2 Pivotal Trial,” said Paul Edwards, President and CEO of Prodeon Medical. “Completing enrollment is a key step in our mission to ...